KOLON LIFE SCIENCE Inc. Logo

KOLON LIFE SCIENCE Inc.

Develops cell/gene therapies and manufactures APIs and specialty chemicals.

102940 | KO

Overview

Corporate Details

ISIN(s):
KR7102940004
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡동로 110 코오롱 One&Only 타워, 서울특별시

Description

KOLON LIFE SCIENCE Inc. is a company operating through two primary business divisions: Bio and Chemical. The Bio division is a clinical-stage biotechnology unit focused on developing novel cell and gene therapies, with a pipeline that includes treatments for neuropathic pain and oncolytic virus therapies for cancer. The Chemical division develops, manufactures, and sells Active Pharmaceutical Ingredients (APIs), specialty chemicals, antimicrobials, and water treatment solutions. The company leverages its expertise in both biotechnology and chemical manufacturing to provide advanced healthcare and environmental products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-06-28 00:00
불성실공시법인지정예고(공시번복 3건)
Korean 7.1 KB
2022-05-31 00:00
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 140.9 KB
2022-05-16 00:00
분기보고서 (2022.03)
Korean 1.5 MB
2022-04-25 00:00
자기주식처분결과보고서
Korean 15.8 KB
2022-04-25 00:00
타법인주식및출자증권취득결정
Korean 25.7 KB
2022-04-13 00:00
투자판단관련주요경영사항(기술수출 계약해지(인보사-케이주))
Korean 9.1 KB
2022-04-13 00:00
투자판단관련주요경영사항(TG-C 기술이전 계약 체결)
Korean 14.1 KB
2022-04-13 00:00
단일판매ㆍ공급계약해지
Korean 9.8 KB
2022-04-13 00:00
[기재정정]투자판단관련주요경영사항(TG-C 기술이전 계약 체결)
Korean 19.2 KB
2022-03-29 00:00
[기재정정]사업보고서 (2021.12)
Korean 2.1 MB
2022-03-24 00:00
정기주주총회결과
Korean 20.7 KB
2022-03-16 00:00
감사보고서제출
Korean 25.7 KB
2022-03-16 00:00
사업보고서 (2021.12)
Korean 598.3 KB
2022-03-15 00:00
특수관계인으로부터자금차입
Korean 6.4 KB
2022-03-08 00:00
주주총회소집공고
Korean 210.3 KB

Automate Your Workflow. Get a real-time feed of all KOLON LIFE SCIENCE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOLON LIFE SCIENCE Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOLON LIFE SCIENCE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.